JPRN-UMIN000012602招募中未知
High-dose methotrexate with rituximab in patients with primary central nervous system lymphoma - High-dose methotrexate with rituximab in patients with primary central nervous system lymphoma
Department of Neurosurgery, Institute of Health Biosciences,The University of Tokushima Graduate School0 个研究点目标入组 30 人开始时间: 2013年12月17日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •serum creatinine >1.3mg/dl, creatinine clearance <75ml/minute, white blood cell count <3000 per dL platelet count <100000 per dL positive for hepatitis B surface antigens, hepatitis C seropositivity pregnancy
研究者
相似试验
尚未招募
不适用
Combination of rituximab and methotrexate followed by rituximab and cytarabine in elderly patients with primary CNS lymphomaKCT0003146Samsung Medical Center35
尚未招募
不适用
Treatment with high dose Methotrexate in patients with generalized eosinophilic fasciitisShulman's syndrome or diffuse fasciitis10010761NL-OMON30014niversitair Medisch Centrum Sint Radboud6
进行中（未招募）
不适用
Treatment with high dose Methotrexate in patients with eosinophilic fasciitis - High dose Methotrexate in eosinophilic fasciitisEosinophilic fasciitis (EF) is a skin disorder involving the deep fascia, resulting in pain and swelling of extremities, cutaneous induration and joint contractures. Most patients require therapy. No controlled trials have been reported. we treated EF patients with intramuscular Methotrexate (MTX)1 mg/kg weekly. In general, the results were not satisfactory and side-effects frequent. With high dose intravenous MTX4 mg/kg every four weeks, we expect a better effect with less side effects.EUCTR2006-003123-37-NLniversity Hospital Sint Radboud
招募中
不适用
Trial of rituximab in patients with rheumatoid arthritisRheumatoid arthritis refractory to standard disease modifying agentsSLCTR/2008/008A Bour & Company (Ltd)40
已完成
2 期
Methotrexate-based Chemo-immunotherapy Followed by Maintenance Therapy for Patients > 65 Years With Central Nervous System (CNS)-Lymphoma (PRIMAIN)primär cerebrales LymphomDRKS00000582niversitätsklinikum Freiburg- vertreten durch:Leitenden Ärztlichen Direktor112